Who is sponsoring NCT03810131?

NCT03810131 is sponsored by Swansea University.

What drugs are being tested in NCT03810131?

Interventions in NCT03810131: 'A Bite of ACT' (BOA).

Is NCT03810131 still recruiting?

NCT03810131 is currently completed. Last updated 22 November 2023.

Last reviewed 2023-11-22 · How we verify

NCT03810131

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study Protocol for a Feasibility Study of a Novel ACT-based eHealth Psychoeducational Intervention for Students With Mental Distress

Completed NA Last updated 22 November 2023

What this trial tests

NA trial testing 'A Bite of ACT' (BOA) in A Bite of ACT' (BOA) Acceptance and Commitment Therapy Online Psychoeducation Course in 60 participants. Completed in 1 November 2023.

Timeline

1 July 2022

Primary endpoint
1 September 2023

1 November 2023

Quick facts

Lead sponsor	Swansea University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	treatment
Enrollment	60
Start date	1 July 2022
Primary completion	1 September 2023
Estimated completion	1 November 2023
Sites	1 location across United Kingdom

Drugs / interventions tested

'A Bite of ACT' (BOA)

Conditions studied

A Bite of ACT' (BOA) Acceptance and Commitment Therapy Online Psychoeducation Course — all drugs for A Bite of ACT' (BOA) Acceptance and Commitment Therapy Online Psychoeducation Course →
A Wait-list Control — all drugs for A Wait-list Control →

Sponsor

Swansea University

Who can join

18 and older, any sex, with A Bite of ACT' (BOA) Acceptance and Commitment Therapy Online Psychoeducation Course or A Wait-list Control. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Here we propose a protocol for assessing the feasibility and acceptability of a randomised controlled trial (RCT) of an online transdiagnostic psychoeducational intervention called 'A Bite of ACT' (BOA) compared to a waitlist control.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Novel ACT-based eHealth psychoeducational intervention for students with mental distress: a study protocol for a mixed-methodology pilot trial.
Edwards DJ, Rainey E, Boukouvala V, Wells Y, et al · · 2019 · cited 3× · PMID 31315873 · DOI 10.1136/bmjopen-2019-029411

Verify or expand the search:

Other Swansea University trials

Trials by the same sponsor.

NCT07452562 — Hesperidin RCT in MS · NA · recruiting
NCT07272096 — ACTing Minds: An ACT-based Videogame for Mental Health · NA · completed
NCT06961513 — Patient Evaluation of Treatment of Pelvic-floor Muscle Dysfunction. · not yet recruiting
NCT06698588 — Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms · NA · recruiting
NCT06407557 — Optimizing Older Adults' Home Space for Physical Activity · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03810131 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Swansea University
Last refreshed: 22 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03810131.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing